Back to search

Virginia Commonwealth University

ENHANCING CHEMOTHERAPEUTIC EFFICACY OF DOXORUBICIN THROUGH COMBINATION THERAPY WITH RAPAMYCIN AND SILDENAFIL, WHILE PROVIDING CARDIOPROTECTION IN BREAST CANCER MODELS

Abstract

dc:description.abstract

Doxorubicin (DOX) is a common chemo-drug for breast cancer, but it causes severe cardiotoxicity. This study explores combining Sildenafil (Sild) and Rapamycin (Rapa), which inhibit phosphodiesterase-5 (PDE5) and mTOR, respectively, to boost DOX’s anticancer, but provide cardioprotection. Triple negative human (MDA-MB-231) and murine (4T1) breast cancer cells were treated with DOX (1 µM) with/without Rapa (100 nM) and Sild (10 µM) for 24-72 hours to analyze cell death, cell viability assays and protein expression. Human epidermal growth factor receptor 2-positive breast cancer (SKBr3) spheroids were treated with the same concentrations of DOX and/or AG825 (5µM) with/without Rapa and/or Sild for 48 hours, followed by 48 hours incubation in fresh medium. The SKBr3 medium was used to treat human cardiomyocytes (AC16) for 48 hours to evaluate cardioprotection. Sild and Rapa combination enhanced DOX-induced killing of all three-breast cancer cells, suppressed mTOR signaling and Bcl2 expression, and increased cleaved PARP in cancer cells, while reducing cardiomyocyte death compared to individual treatment. Adult female C57/B6 mice were treated with DOX (6 mg/kg/twice weekly) for 2 weeks followed by Afatinib (10 mg/kg, oral gavage, 5 days/week) for 2 weeks with/without Rapa (0.25 mg/kg/day) and Sild (1.4 mg/kg/day). After 12 weeks, the combination alleviated DOX+Afatinib-induced cardiac dysfunction with improvement of survival and body weight. This study manifests a unique combination with Sild and Rapa, enhancing chemotherapy efficacy, while safeguarding cardiac function, representing a promising advancement for breast cancer chemo-immunotherapy strategy.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Biology

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mathew, Rebecca
Contributors dc:contributor
  • Dr. Anindita Das

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Mathew, Rebecca. ENHANCING CHEMOTHERAPEUTIC EFFICACY OF DOXORUBICIN THROUGH COMBINATION THERAPY WITH RAPAMYCIN AND SILDENAFIL, WHILE PROVIDING CARDIOPROTECTION IN BREAST CANCER MODELS. Thesis thesis, https://doi.org/10.25772/6VF8-Q737